Partial thromboplastin time
60 results
1 - 60
Partial thromboplastin time
Transfusion Therapy - Coagulation Studies- Russell viper venom time (dRVVT)
- ISOLATED PROLONGATION OF PTT: LABORATORY EVALUATION
- Transfusion Therapy - The Decision to Transfuse
telavancin- BLEEDING DISORDERS, INHERITED: EVALUATION OF SUSPECTED INHERITED BLEEDING DISORDERS
- Protamine
- nusinersen
- olaratumab
- Heparin—Unfractionated
- margetuximab
- brigatinib
- valdecoxib
- fruquintinib
- tafasitamab
- ripretinib
- bazedoxifene/conjugated estrogens
- velaglucerase alfa
- tivozanib
- tisotumab vedotin
- drotrecogin
- Anesthesia for Cardiac Surgery - Preoperative Assessment for Cardiac Surgery
- factor ix (human)
- aprotinin
- Anesthesia for Spine Surgery - Blood Loss
- Argatroban
- pembrolizumab
- hetastarch
- emicizumab
- anticoagulants
- argatroban
- antihemophilic factor
- desirudin
- BLEEDING DISORDERS: LABORATORY EVALUATION
- meropenem
- tirofiban
- avapritinib
- Alteplase
- Anesthesia for Obstetrics and Gynecology - Preeclampsia
- Anesthesia for Trauma and Burns - Initial Evaluation of the Trauma Patient
- tenecteplase
- thrombolytics
- desmopressin
- anistreplase
- urokinase
- reteplase
- streptokinase
- alteplase
- piperacillin/tazobactam
- Normal Values of Common Laboratory Tests
- UNDERLYING ASSUMPTIONS
Hematologic Tests, Diagnostic Interpretation- Mechanical Support of the Failing Heart